Color therapy shows reduced fatigue and depression, improved quality of life in Parkinson's patients
Color therapy study shows possible benefits for Parkinson's fatigue, mood, and quality of life
A randomized controlled trial of 60 Parkinson's patients found that color therapy with purple, yellow, and orange light exposure significant…
Parkinson's patients who viewed colored lights reported less fatigue and depression, plus better quality of life, compared to those receivin…
GLP-1RAs Show No Significant Motor Benefit in Parkinson's Disease Meta-Analysis
GLP-1 drugs show no clear motor benefit for Parkinson's in analysis of 708 patients
A meta-analysis of 5 RCTs involving 708 patients with Parkinson's disease found no statistically significant benefit of GLP-1 receptor agoni…
A new analysis of 708 Parkinson's patients found that diabetes drugs called GLP-1s offered no clear benefit for movement symptoms and caused…
Fatal serotonin syndrome in Parkinson's patient on rasagiline after sequential SSRI administration
Case report describes fatal serotonin syndrome in older Parkinson's patient on multiple medications
A case report describes a 72-year-old Parkinson's patient on rasagiline who developed fatal serotonin syndrome after sequential sertraline a…
A 72-year-old Parkinson's patient died after taking two antidepressants with a genetic makeup that slowed drug processing, causing fatal ser…